Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
120.4 GBX | +1.18% | +1.18% | +21.25% |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
24/04 | Alchemy Fund Sells GBP44.8 Million Mitie Group Shares | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.35 for the 2024 fiscal year.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Sales forecast by analysts have been recently revised upwards.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+21.25% | 1.87B | B+ | ||
+14.11% | 70.02B | B+ | ||
+6.22% | 17.32B | B+ | ||
+13.99% | 14.21B | B- | ||
+20.42% | 13.62B | A- | ||
+15.92% | 9.95B | B- | ||
-1.84% | 6.1B | A- | ||
+3.03% | 5.18B | B- | ||
-1.88% | 4.94B | A- | ||
0.00% | 4.89B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MTO Stock
- Ratings Mitie Group plc